Athira Pharma, Inc. (ATHA) Misses Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts ATHA Hot Sheet
Join SI Premium – FREE
Athira Pharma, Inc. (NASDAQ: ATHA) reported Q3 EPS of ($0.75), $0.05 worse than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Stardust Power (SDST) Tops Q2 EPS by 1c
- Tenon Medical (TNON) Misses Q2 EPS by 395c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
